WO2012093821A3 - 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 - Google Patents
초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 Download PDFInfo
- Publication number
- WO2012093821A3 WO2012093821A3 PCT/KR2012/000021 KR2012000021W WO2012093821A3 WO 2012093821 A3 WO2012093821 A3 WO 2012093821A3 KR 2012000021 W KR2012000021 W KR 2012000021W WO 2012093821 A3 WO2012093821 A3 WO 2012093821A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prognosis
- predicting
- early
- breast cancer
- stage breast
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
Abstract
본 발명은 암의 예후(prognosis) 예측을 위한 유전자의 선정방법, 선정된 암의 예후예측용 유전자 및 이를 이용한 유방암 환자의 전이 예측용 키트 및 예측방법에 관한 것이다. 본 발명은 초기 유방암의 유전적 특성을 분석함으로써 환자의 예후를 간단한 방법을 통해 높은 신뢰도로 예측함으로써 불필요한 항암치료를 줄일 수 있는 예후 진단에 유용하게 이용될 수 있다.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/935,502 US20130344482A1 (en) | 2011-01-04 | 2013-07-04 | Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same |
US15/285,194 US10428386B2 (en) | 2011-01-04 | 2016-10-04 | Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110000521A KR101287600B1 (ko) | 2011-01-04 | 2011-01-04 | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 |
KR10-2011-0000521 | 2011-01-04 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/935,502 Continuation US20130344482A1 (en) | 2011-01-04 | 2013-07-04 | Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012093821A2 WO2012093821A2 (ko) | 2012-07-12 |
WO2012093821A3 true WO2012093821A3 (ko) | 2013-01-24 |
Family
ID=46457820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/000021 WO2012093821A2 (ko) | 2011-01-04 | 2012-01-02 | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 |
Country Status (3)
Country | Link |
---|---|
US (2) | US20130344482A1 (ko) |
KR (1) | KR101287600B1 (ko) |
WO (1) | WO2012093821A2 (ko) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101672531B1 (ko) * | 2013-04-18 | 2016-11-17 | 주식회사 젠큐릭스 | 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도 |
US10655187B2 (en) | 2013-04-18 | 2020-05-19 | Gencurix Inc. | Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof |
KR101748867B1 (ko) * | 2013-04-19 | 2017-06-20 | 주식회사 젠큐릭스 | 조기 유방암 예후 예측 진단용 자동화 시스템 |
KR101548830B1 (ko) * | 2013-12-30 | 2015-08-31 | 가천대학교 산학협력단 | 줄기세포 배양방법을 이용하여 발굴된 유방암 줄기세포 마커를 이용한 유방암 예후 예측용 조성물 |
AU2015230677A1 (en) * | 2014-03-11 | 2016-10-27 | The Council Of The Queensland Institute Of Medical Research | Determining cancer agressiveness, prognosis and responsiveness to treatment |
US20170298443A1 (en) * | 2014-09-25 | 2017-10-19 | Moffitt Genetics Corporation | Prognostic tumor biomarkers |
KR101896558B1 (ko) * | 2016-11-21 | 2018-09-07 | 주식회사 젠큐릭스 | 유방암 환자의 예후 예측 방법 |
KR101950717B1 (ko) | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
KR101896545B1 (ko) | 2016-11-25 | 2018-09-07 | 주식회사 젠큐릭스 | 유방암 환자의 예후 예측 방법 |
KR102071491B1 (ko) | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
CN109841280B (zh) * | 2017-11-29 | 2023-07-21 | 郑州大学第一附属医院 | 食管癌相关特征通路的识别及早期预测模型的构建方法 |
KR102234904B1 (ko) * | 2018-11-30 | 2021-04-01 | 주식회사 쓰리빌리언 | 신규 표적 단백질과 그에 대한 동반진단 바이오마커 발굴 시스템 및 방법 |
KR102188118B1 (ko) * | 2019-04-15 | 2020-12-07 | 인천대학교 산학협력단 | 암에 따른 유전자 간의 상관관계에 기초하여 유전자 분산 표현을 위한 유전자 특징 벡터를 생성하는 전자 장치 및 그 동작 방법 |
CN110257515B (zh) * | 2019-06-14 | 2023-03-31 | 清华-伯克利深圳学院筹备办公室 | 一种用于乳腺癌诊断的分子标志物及其应用 |
CN112168968A (zh) * | 2020-09-25 | 2021-01-05 | 中山大学附属第八医院(深圳福田) | Fto抑制剂在制备防治乳腺癌产品中的应用 |
CN114203255B (zh) * | 2022-02-17 | 2022-06-14 | 北京泽桥医疗科技股份有限公司 | 一种基于机器学习的中药抗癌关键靶标预测方法 |
CN116312802B (zh) * | 2023-02-01 | 2023-11-28 | 中国医学科学院肿瘤医院 | 一种特征基因trim22用于制备调控乳腺癌相关基因表达的试剂的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030078805A (ko) * | 2002-03-29 | 2003-10-08 | 오르토-클리니칼 다이아그노스틱스, 인코포레이티드 | 유방암 예후 포트폴리오 |
WO2004065545A2 (en) * | 2003-01-15 | 2004-08-05 | Rosetta Inpharmatics Llc. | Diagnosis and prognosis of breast cancer patients |
WO2005033699A2 (en) * | 2003-10-03 | 2005-04-14 | Ncc Technology Ventures Pte Limited | Materials and methods relating to breast cancer classification |
US20090239214A1 (en) * | 2004-07-30 | 2009-09-24 | Hongyue Dai | Prognosis of breast cancer patients |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20080742A1 (es) * | 2006-06-02 | 2008-08-06 | Glaxosmithkline Biolog Sa | Perfil genico y procedimiento de identificacion |
-
2011
- 2011-01-04 KR KR1020110000521A patent/KR101287600B1/ko active IP Right Grant
-
2012
- 2012-01-02 WO PCT/KR2012/000021 patent/WO2012093821A2/ko active Application Filing
-
2013
- 2013-07-04 US US13/935,502 patent/US20130344482A1/en not_active Abandoned
-
2016
- 2016-10-04 US US15/285,194 patent/US10428386B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030078805A (ko) * | 2002-03-29 | 2003-10-08 | 오르토-클리니칼 다이아그노스틱스, 인코포레이티드 | 유방암 예후 포트폴리오 |
WO2004065545A2 (en) * | 2003-01-15 | 2004-08-05 | Rosetta Inpharmatics Llc. | Diagnosis and prognosis of breast cancer patients |
WO2005033699A2 (en) * | 2003-10-03 | 2005-04-14 | Ncc Technology Ventures Pte Limited | Materials and methods relating to breast cancer classification |
US20090239214A1 (en) * | 2004-07-30 | 2009-09-24 | Hongyue Dai | Prognosis of breast cancer patients |
Also Published As
Publication number | Publication date |
---|---|
WO2012093821A2 (ko) | 2012-07-12 |
US20190017121A9 (en) | 2019-01-17 |
US10428386B2 (en) | 2019-10-01 |
US20170159126A1 (en) | 2017-06-08 |
KR101287600B1 (ko) | 2013-07-18 |
US20130344482A1 (en) | 2013-12-26 |
KR20120079295A (ko) | 2012-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012093821A3 (ko) | 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법 | |
WO2011095623A3 (en) | miRNA IN THE DIAGNOSIS OF OVARIAN CANCER | |
WO2008104543A3 (en) | Method for predicting the occurrence of metastasis in breast cancer patients | |
GB201021289D0 (en) | Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer | |
MX2014006404A (es) | Metodos y kits para el pronostico del cancer colorrectal. | |
MX2013002084A (es) | Biomarcadores y metodos de tratamiento. | |
WO2012006421A3 (en) | Diagnosis and treatment of breast cancer | |
WO2010102195A3 (en) | Annexin a11 and associated genes as biomarkers for cancer | |
WO2013066369A3 (en) | Methods for detecting graft-versus-host disease | |
WO2012083969A3 (en) | Microrna for diagnosis of pancreatic cancer | |
TN2013000412A1 (en) | Bcma-based stratification and therapy for multiple myeloma patients | |
WO2007140958A3 (en) | Method for identifying whether a patient will be responder or not to immunotherapy | |
MX353482B (es) | Metodos para el tratamiento del cancer y enfermedades inflamatorias utilizando cereblon como predictor. | |
MX2010010387A (es) | Anticuerpos especificos para el complejo de bcr y metodos para el uso de los mismos. | |
WO2011122857A3 (ko) | 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트 | |
MX344543B (es) | Metodos y composiciones para prediccion de riesgo, diagnosis, prognosis y tratamiento de desordenes pulmonares. | |
WO2011112845A3 (en) | Methods and compositions related to a multi-methylation assay to predict patient outcome | |
WO2013025952A3 (en) | Methods and compositions for the treatment and diagnosis of breast cancer | |
MX2013011431A (es) | Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico. | |
WO2014078468A3 (en) | Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent | |
MX357429B (es) | Predictores para el tratamiento del cáncer. | |
WO2011133036A3 (en) | Means and methods for determining risk of cardiovascular disease | |
AU2012371260A8 (en) | Predicitive biomarker for cancer treatment with ADCC enhanced antibodies | |
WO2014038682A3 (en) | Cancer diagnostic and therapeutic method targeting molecules expressed in cancer stem cells | |
EA201490201A1 (ru) | Выявление экспрессии гена prame при раковом заболевании |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12732177 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12732177 Country of ref document: EP Kind code of ref document: A2 |